Exclusive Tiger 21 Club Likes Real Estate, Stocks & Hedge Funds

Tiger 21, the ultra exclusive club with $30,000 annual dues released its “Member Favorites Survey Results” Tuesday. The poll was conducted amongst the club’s 180 members. Collectively, they manage roughly $15B, reports Reuters. “Traditionally, the wealthy share stocks tips and the names of their favorite investment advisors in private, but occasionally a small group of very wealthy investors give outsiders a peek into what they like and where they invested.”

Tiger 21 Members Like Real Estate Best

The Tiger 21 report, which is designed to highlight Members’ favorite investments, found that the group showed a marked preference toward real estate. The report explained the preference by stating, “many Members have created their wealth in this space, understand it, and continue to invest in an area they know well.” Stocks were the next most popular. Members specifically likes Apple Inc (AAPL), Berkshire Hathaway Inc (BRK-A) and General Electric Co (GE). Bank of America (BAC), Citigroup Inc (C) and Wells Fargo & Co (WFC) also made the list.


Hedge Funds Made the Tiger 21 List

Hedge funds were the third most popular investment amongst Tiger 21 members. They accounted for 12% of Member portfolios. It was the highest level hedge funds had seen since 2007. The top hedge fund managers were some of our favorites too – Paul Singer, Robert Zoellner, Kyle Bass, Israel Englander, Norman Miller, Richard Dowdle, David Einhorn, Andreas Halvorsen and John Paulson. According to Reuters, “the group voted Paul Singer, an outspoken investment manager who founded $17 billion Elliott Management, as the best of its “Top 10 Favorite Investment Managers”. There is little discussion why Elliott, which has long treated investors to double-digit returns, beat out the others and Singer himself is named only once.”

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!